LON:FUM Futura Medical (FUM) Share Price, News & Analysis GBX 9 +0.10 (+1.12%) As of 11:50 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About Futura Medical Stock (LON:FUM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Futura Medical alerts:Sign Up Key Stats Today's Range 8.60▼ 950-Day Range 7.20▼ 13.4152-Week Range 7▼ 45.56Volume354,238 shsAverage Volume666,693 shsMarket Capitalization£28.05 millionP/E RatioN/ADividend Yield4.55%Price TargetN/AConsensus RatingN/A Company Overview Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom. Read More Receive FUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FUM Stock News HeadlinesFutura Medical (LON:FUM) Trading Down 6.5% - Time to Sell?August 17, 2025 | americanbankingnews.comFutura Medical Appoints New Interim CEO Amid Strategic ReviewAugust 8, 2025 | tipranks.comThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.August 28 at 2:00 AM | Investors Alley (Ad)Futura Medical Share Chat. Chat About FUM Shares - Stock Quote, Charts ...July 29, 2025 | lse.co.ukFutura Medical PLC (FUM) Stock Price Today - WSJJuly 15, 2025 | wsj.comFutura Stock Price History - Investing.comJune 24, 2025 | investing.comFutura Medical Full Year 2024 Earnings: Beats ExpectationsApril 16, 2025 | finance.yahoo.comFutura Medical (LON:FUM shareholders incur further losses as stock declines 13% this week, taking one-year losses to 63%February 12, 2025 | finance.yahoo.comSee More Headlines FUM Stock Analysis - Frequently Asked Questions How have FUM shares performed this year? Futura Medical's stock was trading at GBX 31.67 on January 1st, 2025. Since then, FUM shares have decreased by 71.6% and is now trading at GBX 9. How were Futura Medical's earnings last quarter? Futura Medical plc (LON:FUM) issued its earnings results on Tuesday, April, 15th. The company reported $0.43 earnings per share for the quarter. Futura Medical had a negative net margin of 44.64% and a negative trailing twelve-month return on equity of 56.44%. How do I buy shares of Futura Medical? Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Futura Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Lloyds Banking Group (LLOY), Bigblu Broadband (BBB), BP (BP), Directa Plus (DCTA) and Genel Energy (GENL). Company Calendar Last Earnings4/15/2025Today8/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:FUM CIKN/A Webwww.futuramedical.com Phone+44-1483-685670FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (1.21) Trailing P/E RatioN/A Forward P/E Ratio3.14 P/E GrowthN/ANet Income-£3.88 million Net Margins-44.64% Pretax MarginN/A Return on Equity-56.44% Return on Assets-26.59% Debt Debt-to-Equity RatioN/A Current Ratio3.75 Quick Ratio5.73 Sales & Book Value Annual Sales£8.68 million Price / Sales3.21 Cash FlowGBX 0.44 per share Price / Cash Flow20.43 Book ValueGBX 2.59 per share Price / Book3.45Miscellaneous Outstanding Shares311,686,179Free FloatN/AMarket Cap£27.85 million OptionableNot Optionable Beta1.25 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (LON:FUM) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Futura Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Futura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.